Abstract
Obesity is a chronic, complex, multifactorial disorder that has
reached epidemic proportions in the United States [1]. Currently,
an estimated 66% of the population is categorized as overweight
or obese, and 32.2% obese [1,2]. Obesity is associated with an
increased risk of morbidity and mortality secondary to complicating
conditions that include heart disease, diabetes, cancer, asthma, sleep
apnea, arthritis, reproductive complications, and psychological
disturbances [3]. Moreover, obesity is associated with greater degrees
of inflammation and oxidative stress, which have recently been
shown to underlie many chronic conditions, from cardiovascular
disease and cancer, to metabolic syndrome and nonalcoholic fatty
liver disease, to neurodegenerative diseases, like Parkinson's disease
[4,5-7]. Given the prevalence of obesity, its harmful consequences
on human health, and the lack of effective treatment options, meal
replacement diet plans represent a viable strategy for controlling
weight and positively impacting health outcomes.
Reference100 articles.
1. 1. Thearle M, Aronne LJ (2003) Obesity and Pharmacologic
2. Therapy. Endocrinol Metab Clin North Am 32: 1005-1024.
3. 2. Ogden CL, Carroll MD, McDowell MA, Flegal KM (2007)
4. Obesity among Adults in the United States - No Statistically
5. Significant Change since 2003-2004. United States Department